• Strategy
  • Payers
  • AI
  • Cybersecurity
  • Device Development
  • Studies/Published Research
  • Ethics
  • Regulatory
  • Digital Biomarkers
  • Data Science
  • Companion Diagnostics
  • Clinical Care
  • Digital Therapeutics
  • Academic Research
  • Virtual Reality
  • RWE
  • Digital Endpoints
  • Medical Devices (Class II and Class III)
  • Commercialization
  • Clinical Trials
  • Drug-Device Combinations
  • SaMD
  • Remote Patient Monitoring
  • Patient Engagement
  • Profiles/Q&A

Pharma USA 2023: Getting Physician Buy-In for Digital Therapeutics

Article

Taking the physician's workflow into account can pave the way for greater acceptance of digital therapeutics.

Tracey Dodenhoff, CEO of Medly Therapeutics, discusses how considering the physician in the digital therapeutics development can help their uptake and acceptance.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.